The Government Pharmaceutical Organization (GPO) has a product to treat COVID-19. Ready to sell to both the public and private sectors. After finding people still infected with COVID-19 In the past week hundreds of people
Dr. Mingkwan Suphanpong, Director of the Government Pharmaceutical Organization, said that from the situation of the COVID-19 outbreak, it was found that Thailand still had people infected with COVID-19. Last week (24 -30 March 2024) there were patients who needed to Approximately 728 people are hospitalized, 215 people have severe pneumonia, 76 patients need to be ventilated, including 2 new deaths, an average of 1 person/week. There is no information indicating that the virus. The strain of COVID-19 that is currently spreading causing more severe illness But the virus has the ability to spread more quickly. In addition, people comply with measures to protect themselves less. As a result, the number of patients still exists. Including some people who have not yet been vaccinated. or not f
ully vaccinated. Currently, the COVID-19 strain that is spreading in Thailand and abroad is the JN.1 strain. Therefore, medical treatment is still necessary (information from the Department of Disease Control as of March 31, 2024).
Director of the Government Pharmaceutical Organization said that in the past the organization Has produced a drug according to treatment guidelines, namely favipiravir. and monovir Or the common name of the drug is Nupiravir mol (Molnupiravir) in capsule form, size 200 milligrams, which is a list of drugs used to treat COVID-19. For patients aged 18 years and older, it is effective. There is a reserve for molnupiravia. adequately and there are raw materials that can produce medicine continuously If you wish to inquire for additional information about the product, contact the Contact Center at 1648 or any of the 8 drug stores of the Government Pharmaceutical Organization.
Source: Thai News Agency